Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,039
Total Claims
$873K
Drug Cost
713
Beneficiaries
$1,225
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 16,767 Hospitalist providers
-73%
Opioid rate vs peers
0.8% vs 3.0% avg
+187%
Cost per patient vs peers
$1,225 vs $427 avg
+226%
Brand preference vs peers
17.1% vs 5.2% avg
Opioid Prescribing
0.8%
Opioid Rate
99
Opioid Claims
$1,065
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,050 claims · $641K
Generic: 9,940 claims · $230K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 309 | $85K |
| Dasatinib | 19 | $47K |
| Insulin Glargine,hum.Rec.Anlog | 89 | $29K |
| Insulin Detemir | 69 | $27K |
| Insulin Aspart | 59 | $27K |
| Empagliflozin | 90 | $25K |
| Insulin Aspart | 52 | $21K |
| Rivaroxaban | 77 | $20K |
| Insulin Glargine,hum.Rec.Anlog | 45 | $17K |
| Semaglutide | 17 | $17K |
| Cariprazine Hcl | 20 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 39 | $13K |
| Linaclotide | 23 | $13K |
| Insulin Detemir | 30 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 44 | $11K |
Prescribing Profile
Patient Profile
75
Avg Age
60%
Female
2.60
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About